Interfaces between cardiovascular and kidney disease among Aboriginal Australians

Advances in Chronic Kidney Disease

Volumn 12, Issue 1, 2005, Pages 39-48

  McDonald, Stephen P ^a   Hoy, Wendy E ^a  

^a QUEEN ELIZABETH HOSPITAL   (Australia)

Author keywords

Aboriginal Australia; albuminuria; cardiovascular disease; indigenous; Kidney disease

Indexed keywords

ABORIGINE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; DIABETES MELLITUS; DISEASE MARKER; ENVIRONMENTAL FACTOR; HUMAN; INFECTION; INFLAMMATION; KIDNEY DISEASE; KIDNEY FAILURE; METABOLIC SYNDROME X; OBESITY; PREVALENCE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SMOKING;

EID: 13844266631     PISSN: 15485595     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ackd.2004.10.015     Document Type: Article

References (99)

1. S.P. McDonald, G.R. Russ The burden of end stage renal disease (ESRD) among indigenous peoples in Australia & New Zealand Kidney Int 63 suppl 2003 S123 127
2. US Renal Data System USRDS 2001 Annual Data Report Atlas of End-Stage Renal Disease in the United States 2001 National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases Bethesda
3. L. Lightstone, A.J. Rees, C. Tomson High incidence of end-stage renal disease in Indo-Asians in the UK QJM 88 1995 191 195
4. M.H. Durie The health of indigenous peoples BMJ 326 2003 510 511
5. P.M. Ridker, M. Cushman, M.J. Stampfer Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men N Engl J Med 336 1997 973 979
6. J. Danesh, R. Collins, P. Appleby Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease Meta-analyses of prospective studies JAMA 279 1998 1477 1482
7. T.B. Harris, L. Ferrucci, R.P. Tracy Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly Am J Med 106 1999 506 512
8. J.W. Yarnell, I.A. Baker, P.M. Sweetnam Fibrinogen, viscosity, and white blood cell count are major risk factors for ischemic heart disease The Caerphilly and Speedwell collaborative heart disease studies Circulation 83 1991 836 844
9. A.R. Folsom, K.K. Wu, W.D. Rosamond Prospective study of hemostatic factors and incidence of coronary heart disease The Atherosclerosis Risk in Communities (ARIC) Study Circulation 96 1997 1102 1108
10. E.B. Rimm, M.J. Stampfer, A. Ascherio Vitamin E consumption and the risk of coronary heart disease in men N Engl J Med 328 1993 1450 1456
11. L.H. Kushi, A.R. Folsom, R.J. Prineas Dietary antioxidant vitamins and death from coronary heart disease in postmenopausal women N Engl J Med 334 1996 1156 1162
12. Homocysteine Studies Collaboration Homocysteine and risk of ischemic heart disease and stroke A meta-analysis JAMA 288 2002 2015 2022
13. J. Zimmermann, S. Herrlinger, A. Pruy Inflammation enhances cardiovascular risk and mortality in hemodialysis patients Kidney Int 55 1999 648 658
14. S.P. McDonald, M.J. Whiting, G.A. Tallis Relationships between homocysteine and related amino acids in chronic hemodialysis patients Clin Nephrol 55 2001 465 470
15. K. Kalantar-Zadeh, P. Stenvinkel, L. Pillon Inflammation and nutrition in renal insufficiency Adv Ren Replace Ther 10 2003 155 169
16. R. Edwards, R. Madden The health and welfare of Australia's Aboriginal and Torres Strait Islander peoples 2001 2001 Australian Bureau of Statistics and Australian Institute of Health and Welfare Canberra
17. Australian Bureau of Statistics: Deaths: Australia, 1996 ABS Catalogue number 3302.0 1997 Australian Bureau of Statistics Canberra
18. K. Dempsey, J. Condon Mortality in the Northern Territory 1979-1997 (ed 1) 1999 Darwin, Territory Health Services
19. S.P. McDonald, G.R. Russ Current incidence, treatment patterns and outcome of end-stage renal disease among indigenous groups in Australia and New Zealand Nephrology 8 2003 42 48
20. J.H. Stewart, M.R. McCredie, S.M. Williams Interpreting incidence trends for treated end-stage renal disease Implications for evaluating disease control in Australia Nephrology 9 2004 238 246
21. A. Cass, J. Cunningham, Z. Wang Regional variation in the incidence of end-stage renal disease in indigenous Australians Med J Aust 175 2001 24 27
22. W.E. Hoy, J.D. Mathews, D.A. McCredie The multidimensional nature of renal disease Rates and associations of albuminuria in an Australian Aboriginal community Kidney Int 54 1998 1296 1304
23. K.G. Rowley, D.M. Iser, J.D. Best Albuminuria in Australian Aboriginal people Prevalence and associations with components of the metabolic syndrome Diabetologia 43 2000 1397 1403
24. S.P. McDonald, G.P. Maguire, W.E. Hoy Renal function and cardiovascular risk markers in a remote Australian Aboriginal community Nephrol Dial Transplant 18 2003 1555 1561
25. C.S. Guest, S. Ratnaike, R.G. Larkins Albuminuria in Aborigines and Europids of south-eastern Australia Med J Aust 159 1993 335 338
26. W. Hoy, Z. Wang, P. van Buynder The natural history of renal disease Part 1 Changes in albuminuria and glomerular filtration rate over time in a community-based cohort of Australian Aborigines with high rates of renal disease. Kidney Int 60 2001 243 248
27. R.M. Smith, R.M. Spargo, E.M. Hunter Prevalence of hypertension in Kimberley Aborigines and its relationship to ischaemic heart disease An age-stratified random survey Med J Aust 156 1992 557 562
28. M. Gracey, R.M. Spargo, P. Smith Risk factors for ill-health in a remote desert-dwelling Aboriginal community in Western Australia Aust N Z J Med 26 1996 171 179
29. C.S. Guest, K. O' Dea, R.G. Larkins Blood pressure, lipids and other risk factors for cardiovascular disease in Aborigines and persons of European descent of southeastern Australia Aust J Public Health 18 1994 79 86
30. J.T. Shaw, B. McWhinney, J.R. Tate Plasma homocysteine levels in indigenous Australians Med J Aust 170 1999 19 22
31. S.P. McDonald, G.P. Maguire, W.E. Hoy Validation of self-reported cigarette smoking in a remote Australian Aboriginal Community Aust NZ J Public Health 27 2003 57 60
32. J. Cunningham Cigarette smoking among indigenous Australians, 1994 Occasional Paper 1996 Australian Bureau of Statistics Canberra
33. J. Cunningham, D. Mackerras Overweight and obesity, indigenous Australians, 1994 Occasional Paper 1998 Australian Bureau of Statistics Canberra
34. I. Rutishauser Body composition in Aboriginal Australians Asia Pacific J Clin Nutr 4 1995 73 76
35. K. Rowley, K. O'Dea, J.D. Best Association of albuminuria and the metabolic syndrome Curr Diabetes Rep 3 2003 80 86
36. S. McDonald, Z. Wang, W. Hoy Physical and biochemical predictors of mortality in an Australian Aboriginal cohort Clin Exp Physiol Pharmacol 26 1999 618 621
37. W. Hoy, Z. Wang, P. van Buynder The natural history of renal disease in Australian Aborigines Part 2 Albuminuria predicts natural death and renal failure. Kidney Int 60 2001 249 256
38. K. Rowley, K.Z. Walker, J. Cohen Inflammation and vascular endothelial activation in an Aboriginal population Relationships to coronary disease risk factors and nutritional markers Med J Aust 178 2003 495 500
39. S.P. McDonald, G.P. Maguire, N.L. Duarte C reactive protein, cardiovascular risk, and renal disease in a remote Australian Aboriginal community Clin Sci (Lond) 106 2003 121 128
40. A. Clough, S. Jacups, Z. Wang Health effects of kava use in an eastern Arnhem Land Aboriginal community Int Med J 33 2003 336 340
41. S.P. McDonald, G.P. Maguire, N.L. Duarte, X.L. Wang, W. Hoy Carotid intima-media thickness, cardiovascular risk factors and albuminuria in a remote Australian Aboriginal community Atherosclerosis 177 2004 423 431
42. K. Rowley, K. O'Dea, Q. Su Low plasma concentrations of diet-derived antioxidants in association with microalbuminuria in indigenous Australian populations Clin Sci (Lond) 105 2003 569 578
43. J. Gutierrez, J. Linares-Palomino, C. Lopez-Espada Chlamydia pneumoniae DNA in the arterial wall of patients with peripheral vascular disease Infection 29 2001 196 200
44. A. Shor, J.I. Phillips Histological and ultrastructural findings suggesting an initiating role for Chlamydia pneumoniae in the pathogenesis of atherosclerosis Cardiovasc J S Afr 11 2000 16 23
45. B. Chiu, E. Viira, W. Tucker Chlamydia pneumoniae, cytomegalovirus, and herpes simplex virus in atherosclerosis of the carotid artery Circulation 96 1997 2144 2148
46. T.M. Lin, W.J. Chen, H.Y. Chen Increased incidence of cytomegalovirus but not Chlamydia pneumoniae in atherosclerotic lesions of arteries of lower extremities from patients with diabetes mellitus undergoing amputation J Clin Pathol 56 2003 429 432
47. M. Davidson, C.C. Kuo, J.P. Middaugh Confirmed previous infection with Chlamydia pneumoniae (TWAR) and its presence in early coronary atherosclerosis Circulation 98 1998 628 633
48. S.P. McDonald Renal Disease, cardiovascular disease and shared risk markers in Aboriginal Communities PhD thesis 2004 Flinders University of SA Adelaide School of Medicine
49. H. Toss, J. Gnarpe, H. Gnarpe Increased fibrinogen levels are associated with persistent Chlamydia pneumoniae infection in unstable coronary artery disease Eur Heart J 19 1998 570 577
50. P.J. Cook, G.Y. Lip, P. Davies Chlamydia pneumoniae antibodies in severe essential hypertension Hypertension 31 1998 589 594
51. J. Danesh, R. Collins, R. Peto Chronic infections and coronary heart disease Is there a link? Lancet 350 1997 430 436
52. A. Hoffmeister, D. Rothenbacher, G. Bode Current infection with Helicobacter pylori, but not seropositivity to Chlamydia pneumoniae or cytomegalovirus, is associated with an atherogenic, modified lipid profile Arterioscler Thromb Vasc Biol 21 2001 427 432
53. A. Szkaradkiewicz, J. Bogaczynska-Staniewicz, L. Torlinski Cytomegalovirus infection and atherogenesis Med Sci Monit 8 2002 CR104 CR107
54. J. Syrjanen, V.V. Valtonen, M. Livanainen, M. Kaste, J.K. Huttunen Preceding infection as an important risk factor for ischaemic brain infarction in young and middle aged patients BMJ 296 1998 1156 1160
55. P. Jousilahti, E. Vartiainen, J. Tuomilehto, P. Puska Symptoms of chronic bronchitis and the risk of coronary disease Lancet 348 1996 567 572
56. K.J. Mattila, M.S. Nieminen, V.V. Valtonen Association between dental health and acute myocardial infarction BMJ 298 1989 779 781
57. M.J. Davies, A.J. Spencer, A. Westwater Dental caries among Australian Aboriginal, non-Aboriginal Australian- born, and overseas-born children Bull World Health Organ 75 1997 197 203
58. W.E. Hoy, R.J. Norman, B.G. Hayhurst A health profile of adults in a Northern Territory Aboriginal community, with an emphasis on preventable morbidities Aust N Z J Public Health 21 1997 121 126
59. M. Arnadottir, B. Hultberg, P. Nilsson-Ehle The effect of reduced glomerular filtration rate on plasma total homocysteine concentration Scand J Clin Lab Invest 56 1996 41 46
60. E.K. Hoogeveen, P.J. Kostense, A. Jager Serum homocysteine level and protein intake are related to risk of microalbuminuria the Hoorn Study Kidney Int 54 1998 203 209
61. L. Davies, E.G. Wilmshurst, A. McElduff The relationship among homocysteine, creatinine clearance, and albuminuria in patients with type 2 diabetes Diabetes Care 24 2001 1805 1809
62. K.G. Rowley, A.J. Lee, D. Yarmirr Homocysteine concentrations lowered following dietary intervention in an aboriginal community Asia Pac J Clin Nutr 12 2003 92 95
63. B.M. McQuillan, J.P. Beilby, M. Nidorf Hyperhomocysteinemia but not the C677T mutation of methylenetetrahydrofolate reductase is an independent risk determinant of carotid wall thickening The Perth Carotid Ultrasound Disease Assessment Study (CUDAS) Circulation 99 1999 2383 2388
64. J. Silberberg, R. Crooks, J. Fryer Fasting and post-methionine homocyst(e)ine levels in a healthy Australian population Aust N Z J Med 27 1997 35 39
65. Z. Wang, W. Hoy A prospective study of albuminuria and incident coronary heart disease in Aboriginal people (abstract) Nephrology 9 supp 1 2004 A2
66. W.E. Hoy, M. Rees, E. Kile A new dimension to the Barker hypothesis Low birthweight and susceptibility to renal disease Kidney Int 56 1999 1072 1077
67. A.V. White, W.E. Hoy, D. McCredie Childhood post-streptococcal glomerulonephritis as a risk factor for chronic renal disease in later life Med J Aust 174 2001 492 496
68. B.M. Brenner, D.L. Garcia, S. Anderson Glomeruli and blood pressure Less of one, more the other? Am J Hypertens 1 1988 335 347
69. G. Keller, G. Zimmer, G. Mall Nephron number in patients with primary hypertension N Engl J Med 348 2003 101 108
70. G.R. Singh, W.E. Hoy Kidney volume, blood pressure and albuminuria Findings in an Australian Aboriginal community Am J Kidney Dis 43 2003 254 259
71. G.V. Raman, A. Clark, S. Campbell Is blood pressure related to kidney size and shape? Nephrol Dial Transplant 13 1998 728 730
72. A.O. Zumrutdal, C. Turan, F. Cetin Relationship between renal size and hypertension in patients with chronic renal failure Nephron 90 2002 145 147
73. W.E. Hoy, R.N. Douglas-Denton, M.D. Hughson A stereological study of glomerular number and volume Preliminary findings in a multiracial study of kidneys at autopsy Kidney Int 83 2003 31 37
74. M. Daniel, K. O'Dea, K.G. Rowley Glycated hemoglobin as an indicator of social environmental stress among indigenous versus westernized populations Prev Med 29 1999 405 413
75. P.Z. Zimmet, D.J. McCarty, M.P. de Courten The global epidemiology of non-insulin-dependent diabetes mellitus and the metabolic syndrome J Diabetes Complications 11 1997 60 68
76. L. Groop, M. Orho-Melander The dysmetabolic syndrome J Intern Med 250 2001 105 120
77. P.M. Ridker, J.E. Buring, N.R. Cook C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events An 8-year follow-up of 14,719 initially healthy American women Circulation 107 2003 391 397
78. E.S. Schaeffner, T. Kurth, G.C. Curhan Cholesterol and the risk of renal dysfunction in apparently healthy men J Am Soc Nephrol 14 2003 2084 2091
79. C.Y. Hsu, D.W. Bates, G.J. Kuperman Diabetes, hemoglobin A1c, cholesterol, and the risk of moderate chronic renal insufficiency in an ambulatory population Am J Kidney Dis 36 2000 272 281
80. W.E. Hoy, M. Rees, E. Kile Low birthweight and renal disease in Australian aborigines Lancet 352 1998 1826 1827
81. J. Spencer, Z. Wang, W. Hoy Low birth weight and reduced renal volume in Aboriginal children Am J Kidney Dis 37 2001 915 920
82. G.R. Singh, W.E. Hoy The association beteen current blood pressure and birth weight a cross sectional study in an Australian Aboriginal community Med J Aust 179 2003 532 535
83. D.J. Barker, P.D. Gluckman, K.M. Godfrey Fetal nutrition and cardiovascular disease in adult life Lancet 341 1993 938 941
84. C.M. Law, D.J. Barker, W.W. Richardson Thinness at birth in a northern industrial town J Epidemiol Community Health 47 1993 255 259
85. H. Hemingway, C.J. Whitty, M. Shipley Psychosocial risk factors for coronary disease in White, South Asian and Afro-Caribbean civil servants The Whitehall II study Ethn Dis 11 2001 391 400
86. M. Bartley, R. Fitzpatrick, D. Firth Social distribution of cardiovascular disease risk factors Change among men in England 1984-1993 J Epidemiol Community Health 54 2000 806 814
87. P. Martikainen, M. Ishizaki, M.G. Marmot Socioeconomic differences in behavioural and biological risk factors A comparison of a Japanese and an English cohort of employed men Int J Epidemiol 30 2001 833 838
88. H.L. Markowe, M.G. Marmot, M.J. Shipley Fibrinogen A possible link between social class and coronary heart disease Br Med J 291 1985 1312 1314
89. T.W. Wilson, G.A. Kaplan, J. Kauhanen Association between plasma fibrinogen concentration and five socioeconomic indices in the Kuopio Ischemic Heart Disease Risk Factor Study Am J Epidemiol 137 1993 292 300
90. M. Kumari, M. Marmot, E. Brunner Social determinants of von Willebrand factor The Whitehall II study Arterioscler Thromb Vasc Biol 20 2000 1842 1847
91. P. Jousilahti, V. Salomaa, V. Rasi Association of markers of systemic inflammation, C reactive protein, serum amyloid A, and fibrinogen, with socioeconomic status J Epidemiol Community Health 57 2003 730 733
92. A. Cass, J. Cunningham, Z. Wang Social disadvantage and variation in the incidence of end-stage renal disease in Australian capital cities Aust N Z J Public Health 25 2001 322 326
93. A. Cass, J. Cunningham, P. Snelling End-stage renal disease in indigenous Australians A disease of disadvantage Ethn Dis 12 2002 373 378
94. E. Breeze, A.E. Fletcher, D.A. Leon Do socioeconomic disadvantages persist into old age? Self-reported morbidity in a 29-year follow-up of the Whitehall Study. Am J Public Health 91 2001 277 283
95. M. Bobak, H.W. Hense, J. Kark An ecological study of determinants of coronary heart disease rates A comparison of Czech, Bavarian and Israeli men Int J Epidemiol 28 1999 437 444
96. M. Bobak, M. Murphy, H. Pikhart Mortality patterns in the Russian Federation indirect technique using widowhood data Bull World Health Organ 80 2002 876 881
97. A.R. Clough, T. Guyula, M. Yunupingu Diversity of substance use in eastern Arnhem Land (Australia) patterns and recent changes Drug Alcohol Rev 21 2002 349 356
98. Australian Bureau of Statistics: Indigenous profile: Australia, 2000 ABS Catalogue number 2002.0 2002 Australian Bureau of Statistics Canberra
99. S.P. McDonald New patients S.P. McDonald G.R. Russ ANZDATA Registry Report 2003 2003 Australia and New Zealand Dialysis and Transplant Registry Adelaide 8 15